Romania's OPCOM electricity spot volumes - Sep 25, 2023
Romania's OPCOM electricity spot prices - Sep 25, 2023
Croatia power consumption - Sep 23, 2023
Serbia power consumption - Sep 23, 2023
Bulgaria power consumption - Sep 23, 2023
Oct 07, 2019 16:41 EEST
October 7 (SeeNews) - Bulgarian drug maker Sopharma [BUL:3JR] said on Monday that its sales revenue increased 2% year-on-year in the first nine months of 2019 on the back of increased sales on the international market.
Sopharma's domestic sales fell 9% year-on-year in january-September, while sales abroad rose 10%, the company said in a bourse filing.
In September alone, sales rose by 31%. Exports were 66% higher on the year, while domestic sales dropped by 5%.
The company did not disclose information about the volumes of its sales revenue.
As at 13:30 CET on Monday, Sopharma shares traded unchanged at 3.34 levs ($1.87/1.70 euro) on the Bulgarian Stock Exchange.
(1 euro = 1.95583 levs)
You have run out of free articles this month.
Sign up in for
and get two (2) free articles more per month or sign up for
and get unlimited access.
Browse our free newsletter options